Skip to content
Home/Companies/MedTech/Kestra Medical Technologies
Kestra Medical Technologies

Kestra Medical Technologies

MedTech·United States·Exited 2025·Held 1yr
Entry
2024
Hold
1yr
Exit
2025

Who owns Kestra Medical Technologies?

Kestra Medical Technologies is an American MedTech company, formerly owned by Andera Partners, exited in 2025 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Andera Partners
Investor
Andera Partners
BioDiscovery 6 · 2022 · VC

Key facts

HQUnited States
SectorMedTech
Websitewww.kestramedical.com
Exit Type
IPO
Exit Year
2025

More from BioDiscovery 6

Other portfolio companies in the same fund.

Inventiva
Inventiva
Active
BiotechFrance· 2024
SciRhom
Active
BiotechFrance· 2024
Abivax
Abivax
Active
BiotechFrance· 2023
Ariceum
Active
BiotechFrance· 2023
BioVentrix
BioVentrix
Active
MedTechFrance· 2023
Dualyx
Active
BiotechFrance· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Kestra Medical Technologies?

Kestra Medical Technologies was formerly owned by Andera Partners, exited in 2025. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue